Which funds bought or sold CAH in Q3 2026?
Cardinal Health Inc. 6 funds bought, 3 sold, out of 109 tracked funds that have filed for Q3 2026. Among active managers, the estimated net flow was −$1.0B.
Holdings as of Sep 30, 2026 (Q3 2026)13F deadline Nov 16, 2026 (45 days after quarter end)
- QRT+$353M
- Arrowstreet+$352M
- Ameriprise+$92M
- Renaissance+$64M
- Man Group+$56M
- MaverickNEW+$2M
- Wellington−$1.1B
- Northern Trust−$66M
- GlenviewOUT−$4M
Top 10 each side. NEW = opened a position, OUT = sold the whole position.
Bought (6)
| Fund | Change | Est. $ | Now |
|---|---|---|---|
| QRT Quant & multi-strategy | Added+1463.1% | +$353M | $378M |
| Arrowstreet Quant & multi-strategy | Added+305.8% | +$352M | $468M |
| Ameriprise Asset manager | Added+31.5% | +$92M | $383M |
| Renaissance Quant & multi-strategy | Added+51.9% | +$64M | $186M |
| Man Group Quant & multi-strategy | Added+26.7% | +$56M | $264M |
| Maverick Hedge fund | New | +$2M | $2M |
Sold (3)
| Fund | Change | Est. $ | Now |
|---|---|---|---|
| Wellington Asset manager | Trimmed-33.6% | −$1.1B | $2.2B |
| Northern Trust Bank & broker | Trimmed-10.4% | −$66M | $572M |
| Glenview Hedge fund | Sold out | −$4M | — |
Source: SEC EDGAR Form 13F-HR for each fund, holdings as of Sep 30, 2026. Shares only (options excluded). Estimated $ = change in shares × quarter-end price. Funds may have traded since. Methodology. Not investment advice.